NOI - Sole Source Lab Service In Vivo.doc
DOC document 57 KB Posted
- Solicitation number
- 1230843
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA-Sole Source-1230843
| Document Type: |
| Notice of Intent to Sole Source |
| Solicitation Number: |
| FDA - Sole Source – 1230843 |
| Posted Date: |
| 07/09/2020 |
| Response Date: |
| 07/16/2020 |
Intends to make a sole source award:
The Food and Drug Administration (FDA) Center for Food Safety and Nutrition (CFSAN) requires laboratory services for in vivo virulence assessment of Vibrio vulnificus isolates.
The award will be made to:
Dr. Salvador Almagro-Moreno The University of Florida 12201 Research Parkway, Suite 501 PO Box 160150
Orlando, Florida 32816-0150
In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The Center for Food Safety and Nutrition (CFSAN) requires laboratory services for in vivo virulence assessment of Vibrio vulnificus isolates.
The contractor shall provide adequate staff with experience in performing the intraperitoneal mouse virulence assay for V. vulnificus, in vivo virulence data on 15 isolates, and a summary of all data and expert interpretations obtained upon completion of the contract. This data is part of the ongoing research program at the FDA/CFSAN/OFS/DSST that cannot be conducted in-house.
Dr. Almagro-Moreno's laboratory is the only laboratory in the country set-up to do the particular in vivo virulence assessment that FDA requires. Dr. Almagro-Moreno and his research team have the ability to conduct the intraperitoneal mouse assay for virulence assessment of V. vulnificus and currently have an International Animal Care and Use Committee (IACUC) approved facility in which to conduct such work.
Dr. Almagro-Moreno at the University of Florida is the only contractor that can provide laboratory services for in vivo virulence assessment of Vibrio vulnificus isolates.
This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within eight (8) days after the publication of this synopsis which shall be considered by the agency. Responses received after 8 days or without the required information may not be considered. For information concerning this acquisition contact:
Tara Hobson
Contract Specialist Email: Tara.Hobson@fda.hhs.gov No phone calls please A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.
1 | Page
File details come from the government source that posted it. Updated .